Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

5,534 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Safety outcomes and immunological correlates in a prospective clinical trial of immune checkpoint therapy plus debulking surgery for patients with metastatic renal cell carcinoma.
Sharma P, Goswami S, Gao J, Basu S, Shapiro D, Karam J, Tidwell R, Ahrar K, Campbell M, Shen Y, Trevino A, Mayer A, Espejo A, Seua C, Macaluso M, Chen Y, Liu W, He Z, Yadav S, Wang Y, Rao P, Zhao L, Zhang J, Jindal S, Futreal A, Wang L, Tannir NM. Sharma P, et al. Among authors: campbell m. Res Sq [Preprint]. 2024 Nov 12:rs.3.rs-4331053. doi: 10.21203/rs.3.rs-4331053/v1. Res Sq. 2024. PMID: 39606482 Free PMC article. Preprint.
A qualitative exploration of the client-provider relationship and its role in discussing sexual health and HIV among African American women in the US South.
Vanderkruik R, Goodman GR, Blyler A, Ott C, Rivas A, Elopre L, Krakower D, Kudroff K, Wise J, Underwood E, McDonald V, Campbell M, Kempf MC, Psaros C. Vanderkruik R, et al. Among authors: campbell m. Sex Reprod Healthc. 2024 Nov 5;42:101043. doi: 10.1016/j.srhc.2024.101043. Online ahead of print. Sex Reprod Healthc. 2024. PMID: 39546962
Multi-platform biomarkers of response to an immune checkpoint inhibitor in the neoadjuvant I-SPY 2 trial for early-stage breast cancer.
Campbell MJ, Wolf DM, Yau C, Brown-Swigart L, Wulfkuhle J, Gallagher IR, Zhu Z, Bolen J, Vandenberg S, Hoyt C, Mori H, Borowsky A, Sit L, Perlmutter J, Asare SM; I-SPY2 Investigators; Nanda R, Liu MC, Yee D, DeMichele AM, Hylton NM, Pusztai L, Berry DA, Hirst GL, Petricoin EF, Veer LV, Esserman L. Campbell MJ, et al. Cell Rep Med. 2024 Nov 19;5(11):101799. doi: 10.1016/j.xcrm.2024.101799. Epub 2024 Nov 6. Cell Rep Med. 2024. PMID: 39510069 Free PMC article.
5,534 results